Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

11,000

Participants

Timeline

Start Date

October 24, 2025

Primary Completion Date

October 29, 2030

Study Completion Date

October 29, 2030

Conditions
High Risk Cardiovascular DiseaseHypertensionHigh Cardiovascular Risk
Interventions
DRUG

Zilebesiran

Zilebesiran will be administered SC

DRUG

Placebo

Placebo will be administered SC

Trial Locations (30)

12553

RECRUITING

Clinical Trial Site, New Windsor

32216

RECRUITING

Clinical Trial Site, Jacksonville

32825

RECRUITING

Clinical Trial Site, Orlando

32934

RECRUITING

Clinical Trial Site, Melbourne

33186

RECRUITING

Clinical Trial Site, Miami

33406

RECRUITING

Clinical Trial Site, Palm Springs

33511

RECRUITING

Clinical Trial Site, Brandon

33615

RECRUITING

Clinical Trial Site, Tampa

37404

RECRUITING

Clinical Trial Site, Chattanooga

37909

RECRUITING

Clinical Trial Site, Knoxville

43213

RECRUITING

Clinical Trial Site, Columbus

43537

RECRUITING

Clinical Trial Site, Maumee

45219

RECRUITING

Clinical Trial Site, Cincinnati

46383

RECRUITING

Clinical Trial Site, Valparaiso

47714

RECRUITING

Clinical Trial Site, Evansville

58104

RECRUITING

Clinical Trial Site, Fargo

60477

RECRUITING

Clinical Trial Site, Flossmoor

72204

RECRUITING

Clinical Trial Site, Little Rock

75024

RECRUITING

Clinical Trial Site, Plano

75071

RECRUITING

Clinical Trial Site, McKinney

75149

RECRUITING

Clinical Trial Site, Mesquite

77002

RECRUITING

Clinical Trial Site, Houston

77036

RECRUITING

Clinical Trial Site, Richmond

77061

RECRUITING

Clinical Trial Site, Houston

77459

RECRUITING

Clinical Trial Site, Missouri City

84025

RECRUITING

Clinical Trial Site, Bountiful

85020

RECRUITING

Clinical Trial Site, Phoenix

85741

RECRUITING

Clinical Trial Site, Tucson

87106

RECRUITING

Clinical Trial Site, Albuquerque

92025

RECRUITING

Clinical Trial Site, Escondido

Sponsors
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Alnylam Pharmaceuticals

INDUSTRY